COVID-19 IN THE MEDIA
COVID-19 Plasma Therapies in Clinical Trials
Developing and trialing an anti-SARS-CoV-2 hyperimmune globulin and convalescent plasma as a direct transfusion therapy, and evaluating the potential efficacy of currently available plasma-derived therapies.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?